Are the “AI ROI” fears already fully priced in? The smart money seems to think we are at least due for a bounce. After weeks of historic, brutal selloffs in the technology sector, hedge funds are quietly stepping back into the market. According to new prime brokerage data from JPMorgan and Goldman Sachs, institutional players...
🇮🇩 PRICING THE UNPREDICTABLE: Indonesia’s Policy Turmoil Sparks an Investor Exodus
Investors don’t demand perfection from Emerging Markets, but they do demand predictability. Right now, Indonesia is struggling to provide it. President Prabowo Subianto’s ambitious “spend-to-grow” agenda (targeting 8% GDP growth by 2029) is colliding with the harsh realities of global capital markets. Following a series of sudden regulatory shifts, a sovereign outlook downgrade from Moody’s,...
🎢 THE RETAIL LEVERAGE BOOM: 90% of Single-Stock ETF Trading Driven by Retail
The gamification of the stock market has found its ultimate weapon. According to a new study co-authored by Direxion, Vanda Research, and The Compound Insights, individual investors are the undisputed whales in the leveraged ETF space. Retail traders now account for nearly 90% of all trading in these high-risk, single-stock speculative vehicles. 📊 THE EXPLOSIVE...
💳 PAYMENTS M&A: PayPal Attracts Takeover Interest Following Historic Stock Slide
Has the original disruptor of digital payments become the sector’s biggest value play? According to a new report from Bloomberg, PayPal (PYPL) is attracting unsolicited takeover interest from potential buyers after a brutal stock slide wiped out almost half of its market value over the past 12 months. The San Jose-based pioneer is now reportedly...
🧬 ONCOLOGY MEGA-DEAL: Gilead Acquires Partner Arcellx for $7.8B to Challenge J&J
The “Try Before You Buy” M&A playbook is alive and well in biotech. Gilead Sciences (GILD) has announced it will acquire its development partner Arcellx (ACLX) for up to $7.8 billion. Marking Gilead’s largest acquisition since its $21 billion buyout of Immunomedics in 2020, the deal is a aggressive strategic pivot to diversify beyond its...
🚨 THE $650B CAPEX BET: Big Tech’s AI Spending Enters a “Dangerous Phase”
The AI arms race is moving from the cloud to the concrete. According to a new analysis by Bridgewater Associates, the four hyperscalers—Alphabet, Amazon, Meta, and Microsoft—are projected to pour an astonishing $650 billion into AI-related infrastructure in 2026. This represents a massive acceleration from $410 billion in 2025, prompting Bridgewater Co-CIO Greg Jensen to...
